Despite a positive trend in favor of a “safe dose” thrombolysis, no significant difference was noted in death rate.
← all excerpts
Efficacy and Safety of Thrombolytic Therapy in Acute Submassive Pulmonary Embolism: Follow-Up Study.
1
—
—
Despite a positive trend in favor of a “safe dose” thrombolysis, no significant difference was noted in death rate.